Kairos Pharma, Ltd. (KAPA) Financials
KAPA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 4.5 million | 265000 |
| March 31, 2026 | 5.7 million | 431000 |
| Dec. 31, 2025 | 6.5 million | 199000 |
| Sept. 30, 2025 | 8.1 million | 402000 |
KAPA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -1.0 million | 259000 |
| March 31, 2026 | -1.0 million | ? |
| Dec. 31, 2025 | -1.1 million | -76000 |
| Sept. 30, 2025 | -838000 | -76000 |
KAPA Net Income
No data available :(
KAPA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 2.6 million | - | - |
| March 31, 2026 | 3.7 million | - | - |
| Dec. 31, 2025 | 4.5 million | - | - |
| Sept. 30, 2025 | 5.6 million | - | - |
KAPA Shares Outstanding
KAPA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 619000 | 798000 | - |
| March 31, 2026 | - | 684000 | 1.0 million | - |
| Dec. 31, 2025 | 838000 | 538000 | 837000 | - |
| Sept. 30, 2025 | 838000 | 608000 | 787000 | - |
KAPA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 40000 |
| Dec. 31, 2025 | - | -120000 |
| Sept. 30, 2025 | - | 40000 |
KAPA
Price: $0.56
52 week price:
Earnings Per Share: -0.27 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 4.8 million